Citation Impact
Citing Papers
Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose
2016
Biogenesis of Influenza A Virus Hemagglutinin Cross-Protective Stem Epitopes
2014 StandoutNobel
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
2018
Bacterial glycosyltransferase-mediated cell-surface chemoenzymatic glycan modification
2019 StandoutNobel
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
2021 StandoutNobel
The evolution and future of influenza pandemic preparedness
2021
An Inhibitory Activity in Human Cells Restricts the Function of an Avian-like Influenza Virus Polymerase
2008 StandoutNobel
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
From Original Antigenic Sin to the Universal Influenza Virus Vaccine
2017
Multi-step prediction for influenza outbreak by an adjusted long short-term memory
2018
Influenza virus hemagglutinin stalk-based antibodies and vaccines
2013
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Lipid nanoparticles for mRNA delivery
2021 Standout
Development of vaccines and antivirals for combating viral pandemics
2020 StandoutNobel
Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination
2020 StandoutNobel
Recent advances in mRNA vaccine technology
2020 StandoutNobel
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
2020 StandoutNobel
Delivery technologies for cancer immunotherapy
2019 Standout
Coronavirus envelope protein: current knowledge
2019 Standout
The scaling laws of human travel
2006 StandoutNature
A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies
2017
Formulation of Microneedles Coated with Influenza Virus-like Particle Vaccine
2010
Novel universal influenza virus vaccine approaches
2016
A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response
2016 StandoutNobel
Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model
2019
Tangential flow microfiltration and ultrafiltration for human influenza A virus concentration and purification
2005
Microneedles for drug and vaccine delivery
2012 Standout
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
2018 StandoutNobel
Physicochemical and Immunological Characterization of N,N,N-Trimethyl Chitosan-Coated Whole Inactivated Influenza Virus Vaccine for Intranasal Administration
2009
Vaccination and antigenic drift in influenza
2008
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model
2017
Nanomaterial Delivery Systems for mRNA Vaccines
2021 StandoutNobel
Advances in the development of influenza virus vaccines
2015
Optimization of Influenza Vaccine Selection
2005
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation
2022 StandoutNobel
Chitosan—A versatile semi-synthetic polymer in biomedical applications
2011 Standout
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
2007 Standout
Overexpression of the α-2,6-Sialyltransferase in MDCK Cells Increases Influenza Virus Sensitivity to Neuraminidase Inhibitors
2003
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
2022 StandoutScienceNobel
Immunogenicity and Protection Efficacy of Replication-Deficient Influenza A Viruses with Altered NS1 Genes
2004
Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice
2019
Supply Chain Coordination and Influenza Vaccination
2008
DNA vaccines: an historical perspective and view to the future
2010
Advanced functional polymer membranes
2006 Standout
Are We Ready for Pandemic Influenza?
2003 Science
Time series analysis and forecasting of coronavirus disease in Indonesia using ARIMA model and PROPHET
2021 Standout
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
Operations Research in Healthcare: a survey
2010 Standout
Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
2023 StandoutNobel
Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice
2019
Influenza A Virus Lacking M2 Protein as a Live Attenuated Vaccine
2009
Challenges of Making Effective Influenza Vaccines
2020
An improved reverse genetics system for influenza A virus generation and its implications for vaccine production
2005
Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice
2015
Works of C. Gerdil being referenced
Selection of Receptor-Binding Variants of Human Influenza A and B Viruses in Baby Hamster Kidney Cells
1999
The annual production cycle for influenza vaccine
2003
Immunogenicity and Protective Efficacy in Mice of Influenza B Virus Vaccines Grown in Mammalian Cells or Embryonated Chicken Eggs
1998
Using the strains and getting the vaccine licensed--a vaccine manufacturer's view.
2003